These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33185256)

  • 101. The Differences between Gluten Sensitivity, Intestinal Biomarkers and Immune Biomarkers in Patients with First-Episode and Chronic Schizophrenia.
    Dzikowski M; Juchnowicz D; Dzikowska I; Rog J; Próchnicki M; Kozioł M; Karakula-Juchnowicz H
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33218214
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Person-based machine learning: Accounting for patient experience to explain the nature of schizophrenia.
    Naslund JA; Hswen Y
    Schizophr Res; 2021 Feb; 228():619-620. PubMed ID: 33229226
    [No Abstract]   [Full Text] [Related]  

  • 103. Characterizing the theory of mind network in schizophrenia reveals a sparser network structure.
    Bitsch F; Berger P; Nagels A; Falkenberg I; Straube B
    Schizophr Res; 2021 Feb; 228():581-589. PubMed ID: 33229225
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Dynamic causal modeling of eye gaze processing in schizophrenia.
    Tso IF; Angstadt M; Rutherford S; Peltier S; Diwadkar VA; Taylor SF
    Schizophr Res; 2021 Mar; 229():112-121. PubMed ID: 33229223
    [TBL] [Abstract][Full Text] [Related]  

  • 105. "I think that everybody should be involved": What informs experiences of shared decision-making in supporting people living with schizophrenia spectrum disorders?
    Carrotte ER; Hartup ME; Lee-Bates B; Blanchard M
    Patient Educ Couns; 2021 Jul; 104(7):1583-1590. PubMed ID: 33229188
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?
    Jen YW; Hwang TJ; Chan HY; Hsieh MH; Liu CC; Liu CM; Hwu HG; Kuo CH; Lin YT; Chien YL; Chen WJ
    BMC Psychiatry; 2020 Nov; 20(1):552. PubMed ID: 33228575
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Characterization of specific and distinct patient types in clinical trials of acute schizophrenia using an uncorrelated PANSS score matrix transform (UPSM).
    Hopkins SC; Ogirala A; Loebel A; Koblan KS
    Psychiatry Res; 2020 Dec; 294():113569. PubMed ID: 33223272
    [TBL] [Abstract][Full Text] [Related]  

  • 108. A combination of three plasma bile acids as a putative biomarker for schizophrenia.
    Tao Y; Zheng F; Cui D; Huang F; Wu X
    Acta Neuropsychiatr; 2021 Feb; 33(1):51-54. PubMed ID: 33222705
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Assessing the efficacy and feasibility of providing metacognitive training for patients with schizophrenia by mental health nurses: A randomized controlled trial.
    de Pinho LMG; Sequeira CADC; Sampaio FMC; Rocha NB; Ozaslan Z; Ferre-Grau C
    J Adv Nurs; 2021 Feb; 77(2):999-1012. PubMed ID: 33222210
    [TBL] [Abstract][Full Text] [Related]  

  • 110. A common variation in HCN1 is associated with heart rate variability in schizophrenia.
    Refisch A; Chung HY; Komatsuzaki S; Schumann A; Mühleisen TW; Nöthen MM; Hübner CA; Bär KJ
    Schizophr Res; 2021 Mar; 229():73-79. PubMed ID: 33221148
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission.
    Fond G; Faugere M; Richieri R; Cermolacce M; Korchia T; Micoulaud-Franchi JA; Sunhary de Verville PL; Boyer L; Lançon C
    J Affect Disord; 2021 Feb; 280(Pt A):267-271. PubMed ID: 33220563
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Treating disorders across the lifespan by modulating cholinergic signaling with galantamine.
    Metz CN; Pavlov VA
    J Neurochem; 2021 Sep; 158(6):1359-1380. PubMed ID: 33219523
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Feeling responsible: Family caregivers' attitudes and experiences of shared decision-making regarding people diagnosed with schizophrenia: A qualitative study.
    Huang C; Lam L; Plummer V; Cross WM
    Patient Educ Couns; 2021 Jul; 104(7):1553-1559. PubMed ID: 33218782
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Assessing the relationship between routine and schizophrenia symptoms with passively sensed measures of behavioral stability.
    He-Yueya J; Buck B; Campbell A; Choudhury T; Kane JM; Ben-Zeev D; Althoff T
    NPJ Schizophr; 2020 Nov; 6(1):35. PubMed ID: 33230099
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Metacognitive preserved generation strategy benefits for both younger and elderly participants with schizophrenia.
    Izaute M; Thuaire F; Méot A; Rondepierre F; Jalenques I
    PLoS One; 2020; 15(11):e0241356. PubMed ID: 33216755
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Effectiveness of antipsychotic drugs in schizophrenia: a 10-year retrospective study in a Korean tertiary hospital.
    Oh S; Lee TY; Kim M; Kim SH; Lee S; Cho S; Kim JH; Kwon JS
    NPJ Schizophr; 2020 Nov; 6(1):32. PubMed ID: 33214559
    [TBL] [Abstract][Full Text] [Related]  

  • 117. PCM1 is necessary for focal ciliary integrity and is a candidate for severe schizophrenia.
    Monroe TO; Garrett ME; Kousi M; Rodriguiz RM; Moon S; Bai Y; Brodar SC; Soldano KL; Savage J; Hansen TF; Muzny DM; Gibbs RA; Barak L; Sullivan PF; Ashley-Koch AE; Sawa A; Wetsel WC; Werge T; Katsanis N
    Nat Commun; 2020 Nov; 11(1):5903. PubMed ID: 33214552
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Predictive value of oxidative stress biomarkers in drug‑free patients with schizophrenia and schizo-affective disorder.
    Guidara W; Messedi M; Naifar M; Maalej M; Grayaa S; Omri S; Ben Thabet J; Maalej M; Charfi N; Ayadi F
    Psychiatry Res; 2020 Nov; 293():113467. PubMed ID: 33198042
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study.
    Zhou X; Wang X; Li R; Yan J; Xiao Y; Li W; Shen H
    Front Psychiatry; 2020; 11():581061. PubMed ID: 33192726
    [No Abstract]   [Full Text] [Related]  

  • 120. Deep Learning-Based Human Activity Recognition for Continuous Activity and Gesture Monitoring for Schizophrenia Patients With Negative Symptoms.
    Umbricht D; Cheng WY; Lipsmeier F; Bamdadian A; Lindemann M
    Front Psychiatry; 2020; 11():574375. PubMed ID: 33192706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.